Effettuare il login Iscriviti gratis

Apellis Pharmaceuticals Inc Obiettivo di 1 anno

Cos'è Obiettivo di 1 anno di Apellis Pharmaceuticals Inc?

Obiettivo di 1 anno di Apellis Pharmaceuticals Inc è $53 +37.62%

Qual è la definizione di Obiettivo di 1 anno?

L'obiettivo a 1 anno è un prezzo azionario previsto tra un anno.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

Obiettivo di 1 anno di aziende nel Health Care settore su NASDAQ rispetto a Apellis Pharmaceuticals Inc

Cosa fa Apellis Pharmaceuticals Inc?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Aziende con obiettivo di 1 anno simili a Apellis Pharmaceuticals Inc